Two M.D.s discuss CME courses that help physicians understand cannabis. They also answer the question, “Is medical marijuana safer than Tylenol?”
Dr. Gina Berman and Lilach Mazor Power discuss their holistic approach toward helping patients recover from opiate addiction with cannabis treatment
The importance of establishing unified cannabis standards can’t be underestimated. Snowden Bishop interviews the founder of FOCUS, who is doing just that.
ASTM International will host a meeting of a new technical committee to develop voluntary cannabis standards on Feb. 28, at 9 a.m. EST in West Conshohocken, Pa.
Snowden Bishop interviews former Goldman Sachs banker, Hadley Ford, about cannabis stocks and investing in the big business of marijuana
Interview with Nurse Heather Manus and attorney Ken Sobel about suing the State of Arizona to add PTSD as a qualifying condition for medical marijuana.
As the first comprehensive study to be conducted by a Federally sanctioned institution, the NAS study has potential to expose the fallacy of the classification of cannabis as a Schedule 1 controlled substance.
Interview with Dr. Sue Sisley and Dr. Bryan Doner, who have dedicated their careers advocating for more clinical cannabis study and education for medical practitioners.
Interview with medical marijuana expert, Dr. Stuart Titus, who is pioneering efforts to help families of epileptic children access CBD in Mexico and Brazil
With medical marijuana legal in 29 states and patient demand for information at an all-time high, medical practitioners have a questions. It’s time to educate doctors!
Interview with a lawyer, a journalist and a parent on the media frenzy over the DEA announcement about CBD and Schedule 1 Controlled Substances
If the future of hemp-derrived CBD is looking bleak, take heart. The DEA ruling as published in this week’s Federal Registry does not make CBD illegal.